Literature DB >> 17929935

Latrunculin with a highly oxidized thiazolidinone ring: structure assignment and actin docking.

Safwat A Ahmed1, Srinivas Odde, Pankaj R Daga, John J Bowling, Mostafa K Mesbah, Diaa T Youssef, Sherief I Khalifa, Robert J Doerksen, Mark T Hamann.   

Abstract

A new latrunculin, oxalatrunculin B (3), was isolated from Red Sea sponge Negombata corticata. Extensive spectroscopic analysis revealed an unprecedented heterocycle in which the rare thiazolidinone ring found in latrunculins was oxidized with three additional oxygens. An actin polymerization inhibition assay agreed with MM-PBSA free energy calculations that 3 binds more weakly than latrunculin B to actin. Significant antifungal and anticancer activity of 3 was found, suggesting an alternate target in addition to actin for latrunculin bioactivity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17929935      PMCID: PMC2529398          DOI: 10.1021/ol7020675

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  7 in total

1.  Toward computing relative configurations: 16-epi-latrunculin B, a new stereoisomer of the actin polymerization inhibitor latrunculin B.

Authors:  Thomas R Hoye; Seif-Eldin N Ayyad; Brian M Eklov; Nadia E Hashish; W Thomas Shier; Khalid A El-Sayed; Mark T Hamann
Journal:  J Am Chem Soc       Date:  2002-06-26       Impact factor: 15.419

2.  Actin crystal dynamics: structural implications for F-actin nucleation, polymerization, and branching mediated by the anti-parallel dimer.

Authors:  Robbie Reutzel; Craig Yoshioka; Lakshmanan Govindasamy; Elena G Yarmola; Mavis Agbandje-McKenna; Michael R Bubb; Robert McKenna
Journal:  J Struct Biol       Date:  2004-06       Impact factor: 2.867

3.  Latrunculins: novel marine toxins that disrupt microfilament organization in cultured cells.

Authors:  I Spector; N R Shochet; Y Kashman; A Groweiss
Journal:  Science       Date:  1983-02-04       Impact factor: 47.728

Review 4.  Regulation of cancer cell motility through actin reorganization.

Authors:  Daisuke Yamazaki; Shusaku Kurisu; Tadaomi Takenawa
Journal:  Cancer Sci       Date:  2005-07       Impact factor: 6.716

5.  Intramolecular Diels-Alder Reaction of N-Alkyl-2-cyano-1-azadienes: A Study of the Eschenmoser Cycloreversion of Dihydrooxazines as a Route to N-Alkyl-2-cyano-1-azadienes.

Authors:  Irina A. Motorina; Frank W. Fowler; David S. Grierson
Journal:  J Org Chem       Date:  1997-04-04       Impact factor: 4.354

6.  Latrunculin analogues with improved biological profiles by "diverted total synthesis": preparation, evaluation, and computational analysis.

Authors:  Alois Fürstner; Douglas Kirk; Michaël D B Fenster; Christophe Aïssa; Dominic De Souza; Cristina Nevado; Tell Tuttle; Walter Thiel; Oliver Müller
Journal:  Chemistry       Date:  2007       Impact factor: 5.236

7.  Bioactive natural and semisynthetic latrunculins.

Authors:  Khalid A El Sayed; Diaa T A Youssef; Dario Marchetti
Journal:  J Nat Prod       Date:  2006-02       Impact factor: 4.050

  7 in total
  12 in total

1.  Natural product libraries to accelerate the high-throughput discovery of therapeutic leads.

Authors:  Tyler A Johnson; Johann Sohn; Wayne D Inman; Samarkand A Estee; Steven T Loveridge; Helene C Vervoort; Karen Tenney; Junke Liu; Kenny Kean-Hooi Ang; Joseline Ratnam; Walter M Bray; Nadine C Gassner; Young Y Shen; R Scott Lokey; James H McKerrow; Kyria Boundy-Mills; Arif Nukanto; Atit Kanti; Heddy Julistiono; Leonardus B S Kardono; Leonard F Bjeldanes; Phillip Crews
Journal:  J Nat Prod       Date:  2011-11-30       Impact factor: 4.050

Review 2.  Bioactive heterocycles containing endocyclic N-hydroxy groups.

Authors:  Reshma Rani; Carlotta Granchi
Journal:  Eur J Med Chem       Date:  2014-11-18       Impact factor: 6.514

3.  Biostructural features of additional jasplakinolide (jaspamide) analogues.

Authors:  Katharine R Watts; Brandon I Morinaka; Taro Amagata; Sarah J Robinson; Karen Tenney; Walter M Bray; Nadine C Gassner; R Scott Lokey; Joseph Media; Frederick A Valeriote; Phillip Crews
Journal:  J Nat Prod       Date:  2011-01-11       Impact factor: 4.050

4.  Antiepileptic ceramides from the Red Sea sponge Negombata corticata.

Authors:  Safwat A Ahmed; Sherief I Khalifa; Mark T Hamann
Journal:  J Nat Prod       Date:  2008-03-21       Impact factor: 4.050

Review 5.  A selective account of effective paradigms and significant outcomes in the discovery of inspirational marine natural products.

Authors:  Koneni V Sashidhara; Kimberly N White; Phillip Crews
Journal:  J Nat Prod       Date:  2009-03-27       Impact factor: 4.050

6.  Interrogating the bioactive pharmacophore of the latrunculin chemotype by investigating the metabolites of two taxonomically unrelated sponges.

Authors:  Taro Amagata; Tyler A Johnson; Robert H Cichewicz; Karen Tenney; Susan L Mooberry; Joseph Media; Matthew Edelstein; Frederick A Valeriote; Phillip Crews
Journal:  J Med Chem       Date:  2008-11-27       Impact factor: 7.446

7.  Semisynthetic latrunculin B analogs: studies of actin docking support a proposed mechanism for latrunculin bioactivity.

Authors:  Sucheta Kudrimoti; Safwat A Ahmed; Pankaj R Daga; Amir E Wahba; Sherief I Khalifa; Robert J Doerksen; Mark T Hamann
Journal:  Bioorg Med Chem       Date:  2009-09-16       Impact factor: 3.641

8.  Development and validation of a rapid method for the detection of latrunculol A in plasma.

Authors:  Jiajiu Shaw; Frederick A Valeriote; Joseph Media; Tyler A Johnson; Taro Amagata; Karen Tenney; Phillip Crews
Journal:  Anal Bioanal Chem       Date:  2009-12-31       Impact factor: 4.142

9.  Total synthesis of (+)-18-epi-latrunculol A: development of a synthetic route.

Authors:  Brett D Williams; Amos B Smith
Journal:  J Org Chem       Date:  2014-09-22       Impact factor: 4.354

Review 10.  Migrastatics-Anti-metastatic and Anti-invasion Drugs: Promises and Challenges.

Authors:  Aneta Gandalovičová; Daniel Rosel; Michael Fernandes; Pavel Veselý; Petr Heneberg; Vladimír Čermák; Luboš Petruželka; Sunil Kumar; Victoria Sanz-Moreno; Jan Brábek
Journal:  Trends Cancer       Date:  2017-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.